Taiwan Biophotonic Co. (tBPC)

funded by a team spun off from ITRI on April 22, 2014, targets itself as the global leading biophotonic company with full operations in research and development, manufacturing, marketing and sales of medical and healthcare related products and services. Core technologies of tBPC will include noninvasive glucose meter and wearable vital sign monitoring devices.